Histologic Findings of Femoral Heads From Patients With Gaucher Disease Treated With Enzyme Replacement

被引:9
|
作者
Lebel, Ehud [1 ]
Elstein, Deborah [2 ]
Peleg, Ariel [2 ]
Remus, Constantine [3 ]
Zimran, Ari [2 ]
Amir, Gail [4 ]
机构
[1] Shaare Zedek Med Ctr, Dept Orthoped Surg, IL-91031 Jerusalem, Israel
[2] Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel
[3] Shaare Zedek Med Ctr, Dept Pathol, IL-91031 Jerusalem, Israel
[4] Hadassah Med Ctr, Dept Pathol, Ein Kerem, Israel
关键词
Gaucher disease; Gaucher cells; Bone histology; Enzyme replacement therapy; Osteonecrosis; OSTEONECROSIS;
D O I
10.1309/AJCPFVSAEGO67NGT
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: To assess correlations of patient demographics, including enzyme replacement therapy (ERT) with bone histology, to facilitate decisions of whether and when to perform hip replacement surgery in patients with Gaucher disease. Methods: We examined the histology of surgically removed femoral heads and categorized findings by the presence or extent of osteonecrosis, Gaucher cell (GC) infiltration, and bone regeneration qualifiers using a tripartite histology-based scoring system. Results: Twenty-two patients with 26 bone specimens were evaluated. Seventeen patients (77%) were splenectomized, 16 (73%) received ERT, and 12 (55%) had the putatively milder genotype (N370S/N370S), with the rest putatively at increased risk for skeletal disease (N370S/other). The 3 histology subscores were applicable to all specimens. Osteonecrotic bone was seen in 19 of 26 (73%); osteoarthritis was seen in all cartilage specimens. Gaucher cell infiltration was not correlated with demographics or disease severity. A trend was noted between reduced GC infiltration and ERT (rho = 0.407), but regeneration qualifiers were not correlated with ERT or other features. Conclusions: Histologic findings of GC infiltration and bone regeneration qualifiers did not correlate with demographics or with exposure to ERT. Most specimens unexpectedly showed good regenerative responses to osteonecrosis despite heavy GC infiltration.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 50 条
  • [31] Effect of enzyme replacement therapy on lipid profile in patients with Gaucher's disease
    Alfonso, P
    Cenarro, A
    Pérez-Calvo, JI
    Puzo, J
    Giralt, M
    Giraldo, P
    Pocoví, M
    MEDICINA CLINICA, 2003, 120 (17): : 641 - 646
  • [32] Causes of death in 184 patients with type 1 Gaucher disease from the United States who were never treated with enzyme replacement therapy
    Weinreb, Neal J.
    Barbouth, Deborah S.
    Lee, Robert E.
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 211 - 217
  • [33] Enzyme replacement therapy in pediatric patients with Gaucher disease: What should we use as maintenance dosage?
    Brunel-Guitton, Catherine
    Rivard, Georges-Etienne
    Galipeau, Jacques
    Alos, Nathalie
    Miron, Marie-Claude
    Therrien, Roxane
    Mitchell, Grant
    Lapierre, Guy
    Lambert, Marie
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (02) : 73 - 76
  • [34] The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease
    Charrow, J.
    Dulisse, B.
    Grabowski, G. A.
    Weinreb, N. J.
    CLINICAL GENETICS, 2007, 71 (03) : 205 - 211
  • [35] Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients
    Dahl, Stephan vom
    Poll, Ludger
    Di Rocco, Maja
    Ciana, Giovanni
    Denes, Carmencita
    Mariani, Giuliano
    Maas, Mario
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (06) : 1045 - 1064
  • [36] Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model
    Marie Vigan
    Jérôme Stirnemann
    Catherine Caillaud
    Roseline Froissart
    Anne Boutten
    Bruno Fantin
    Nadia Belmatoug
    France Mentré
    Orphanet Journal of Rare Diseases, 9
  • [37] Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model
    Vigan, Marie
    Stirnemann, Jerome
    Caillaud, Catherine
    Froissart, Roseline
    Boutten, Anne
    Fantin, Bruno
    Belmatoug, Nadia
    Mentre, France
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
  • [38] Computerized cognitive testing in patients with type I Gaucher disease: Effects of enzyme replacement and substrate reduction
    Elstein, D
    Guedalia, J
    Doniger, GM
    Simon, ES
    Antebi, V
    Arnon, Y
    Zimran, A
    GENETICS IN MEDICINE, 2005, 7 (02) : 124 - 130
  • [39] Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy
    Mclntosh, Paul T.
    Hobson-Webb, Lisa D.
    Kazi, Zoheb B.
    Prater, Sean N.
    Banugaria, Suhrad G.
    Austin, Stephanie
    Wang, Raymond
    Enterline, David S.
    Frush, Donald P.
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : 85 - 91
  • [40] Regression of skeletal changes in type 1 Gaucher disease with enzyme replacement therapy
    Pastores, GM
    Hermann, G
    Norton, KI
    Lorberboym, M
    Desnick, RJ
    SKELETAL RADIOLOGY, 1996, 25 (05) : 485 - 488